PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization.
about
Cordyceps cicadae induces G2/M cell cycle arrest in MHCC97H human hepatocellular carcinoma cells: a proteomic studyCancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs.The GDA1_CD39 superfamily: NTPDases with diverse functions.ENTPD5 induces apoptosis in lung cancer cells via regulating caspase 3 expression.p22phox confers resistance to cisplatin, by blocking its entry into the nucleus.The La protein counteracts cisplatin-induced cell death by stimulating protein synthesis of anti-apoptotic factor Bcl2.The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family.Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA libraryCaveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation.Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin.NTPDase5/PCPH as a new target in highly aggressive tumors: a systematic reviewCisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells.Norcantharidin induces autophagy-related prostate cancer cell death through Beclin-1 upregulation by miR-129-5p suppression.VEGF-activated miR-144 regulates autophagic survival of prostate cancer cells against Cisplatin.P2Y11 impairs cell proliferation by induction of cell cycle arrest and sensitizes endothelial cells to cisplatin-induced cell death.Protein Kinase C (PKC) Isozymes and Cancer
P2860
Q33676456-5116B2D9-4CEC-479E-AC7D-93C5BA5CFA75Q34074238-F4A2F29F-B8AB-4247-8535-A2FFCC474C4AQ34868468-27095468-29F9-42F1-9786-55614650F18FQ35202837-3EFB37A0-DFDB-4088-A3A3-9FA99727AE3DQ35551953-71D9C3FE-8A65-4E62-B334-53A3E60E5D5AQ37301910-19F55B48-E0F6-4DE4-A4BD-85F42CECDB81Q37313396-3A844D4A-005D-4565-BC82-ADE6C5B0BA4FQ37446629-05320AFB-AE70-4E04-A0AB-1152AB87D3DDQ37480142-9DEEA27B-ADBD-4722-A7A0-02A958351141Q37551919-1470852B-DF35-4C17-BAAC-8006A85245D0Q38232084-64234384-8F1C-4449-90D6-F5ADCE6C4973Q39535128-5FE3CA0F-3239-4CE6-BC2B-4B6C470A048DQ40241247-F7627C1A-1832-4219-8C00-4AE7A702173BQ40323358-35C9234A-9D6C-4287-A837-9E048C9F5517Q42742419-106983E0-1074-4F14-9F21-0CF7BA17EE0FQ59072618-469CB0B2-0EEE-404C-B3A4-0EF0F902553B
P2860
PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PCPH/ENTPD5 expression confers ...... -mediated Bcl-2 stabilization.
@en
PCPH/ENTPD5 expression confers ...... -mediated Bcl-2 stabilization.
@nl
type
label
PCPH/ENTPD5 expression confers ...... -mediated Bcl-2 stabilization.
@en
PCPH/ENTPD5 expression confers ...... -mediated Bcl-2 stabilization.
@nl
prefLabel
PCPH/ENTPD5 expression confers ...... -mediated Bcl-2 stabilization.
@en
PCPH/ENTPD5 expression confers ...... -mediated Bcl-2 stabilization.
@nl
P2093
P2860
P1433
P1476
PCPH/ENTPD5 expression confers ...... -mediated Bcl-2 stabilization.
@en
P2093
Humair S Quadri
Insun Song
Joaquín Villar
Oscar M Tirado
Vicente Notario
York Tomita
P2860
P304
P356
10.1158/0008-5472.CAN-08-2922
P407
P577
2009-01-01T00:00:00Z